Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.

作者: Xuhong Liu , Chunhong Hu

DOI: 10.1016/J.OMTM.2020.07.017

关键词:

摘要: E2F transcription factors (E2Fs) were found to be related with cell activities and disease progression among a variety of different tumors, including regulating division proliferation. In the analysis, it aimed focus on transcriptional survival information E2Fs in gastric cancer (GC) from Gene Expression Profiling Interactive Analysis (GEPIA), Kaplan-Meier plotter, cBioPortal, Database for Annotation, Visualization Integrated Discovery (DAVID), Kyoto Encyclopedia Genes Genomes (KEGG) pathway, Oncomine databases. It was that expression E2F1/2/3/5/7/8 GC tissues obviously higher than normal. Of interest, none pathological stages. Nevertheless, high E2F2/3/5/7/8 better data, except E2F6 regarding shorter first-progression (FP) survival. High levels E2F2/5/7/8 have significant correlations overall (OS) patients intestinal diffuse GC, this prognostic value is not affected by gender. Oppositely, lower level E2F1/4 illustrated superior data. Moreover, increased E2F1 might play an important role development GC. Collectively, could potential therapeutic target original predictors

参考文章(61)
J R Nevins, Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth & Differentiation. ,vol. 9, pp. 585- 593 ,(1998)
Xiaoping Li, Hong Li, Rui Zhang, Jing Liu, Jun Liu, MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer. Cellular Physiology and Biochemistry. ,vol. 35, pp. 2033- 2042 ,(2015) , 10.1159/000374010
Yanyan Zhou, Lan Wen, Fangzhi Cheng, Chunhua Yin, MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2. Saudi Journal of Gastroenterology. ,vol. 21, pp. 313- 319 ,(2015) , 10.4103/1319-3767.166206
Zhanjiang Yu, Wei Zhang, Fengchun Deng, MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3 Oncology Letters. ,vol. 10, pp. 1447- 1452 ,(2015) , 10.3892/OL.2015.3390
Dong Kyun Woo, Won Ae Lee, Yong Il Kim, Woo Ho Kim, Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach Pathology International. ,vol. 50, pp. 690- 695 ,(2000) , 10.1046/J.1440-1827.2000.01105.X
T Barrette, A Pandey, AM Chinnaiyan, ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform Neoplasia. ,vol. 6, pp. 1- 6 ,(2004) , 10.1016/S1476-5586(04)80047-2
Ju-gang Wu, Ji-wei Yu, Hong-biao Wu, Lin-hai Zheng, Xiao-chun Ni, Xiao-qiang Li, Guang-ye Du, Bo-jian Jiang, Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma BMC Research Notes. ,vol. 7, pp. 6- 6 ,(2014) , 10.1186/1756-0500-7-6
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Hui-Zi Chen, Shih-Yin Tsai, Gustavo Leone, Emerging roles of E2Fs in cancer: an exit from cell cycle control Nature Reviews Cancer. ,vol. 9, pp. 785- 797 ,(2009) , 10.1038/NRC2696
S Semba, H Ouyang, S Y Han, Y Kato, A Horii, Analysis of the candidate target genes for mutation in microsatellite instability-positive cancers of the colorectum, stomach, and endometrium. International Journal of Oncology. ,vol. 16, pp. 731- 737 ,(2000) , 10.3892/IJO.16.4.731